Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.65 and traded as low as $1.51. BioRestorative Therapies shares last traded at $1.53, with a volume of 5,443 shares changing hands.
BioRestorative Therapies Price Performance
The stock has a market capitalization of $10.36 million, a price-to-earnings ratio of -0.66 and a beta of 63.07. The business’s 50-day simple moving average is $1.64 and its two-hundred day simple moving average is $1.50.
BioRestorative Therapies (OTCMKTS:BRTX – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.50) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.06. The firm had revenue of $0.09 million for the quarter, compared to analysts’ expectations of $0.03 million. BioRestorative Therapies had a negative net margin of 13,728.83% and a negative return on equity of 120.47%. As a group, sell-side analysts expect that BioRestorative Therapies, Inc. will post -3.52 EPS for the current year.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- What is a Death Cross in Stocks?
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- What is a Bond Market Holiday? How to Invest and Trade
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- What is a SEC Filing?
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.